Education

Ph.D. in Cell Biology, School of Life Science, University of Science and Technology of China, Hefei, China, 2008

Current position

Research Fellow, Laboratory of Experimental Immunology, Cancer and Inflammation Program, NCI-Frederick, MD, USA, 2014

Publications

1. Chen, K., Xiang, Y., Huang, J., Gong, W., Yoshimura, T., Jiang, Q., Tessarollo, L., Le, Y. and Wang, J. M. (2014). The formylpeptide receptor2 (Fpr2) and its endogenous ligand CRAMP promote dendritic cell maturation. J Biol Chem. (Epub ahead of print)
   
2. Xiao, Z., Jiang, Q., Willette-Brown, J. and Hu, Y. (2013). Mouse model resembling human lung cancer. Oncotarget 4(6): 810-811.
   
3. Xiao, Z.*, Jiang, Q.*, Willette-Brown, J., Xi, S., Zhu, F., Burkett, S., Back, T., Song, N. Y., Datla, M., Sun, Z., Goldszmid, R., Lin, F., Cohoon, T., Pike, K., Wu, X., Schrump, D. S., Wong, K. K., Young, H. A., Trinchieri, G., Wiltrout, R. H. and Hu, Y. (2013). The pivotal role of IKKalpha in the development of spontaneous lung squamous cell carcinomas. Cancer Cell 23(4): 527-540. (*Contribute equally)
   
4. Jiang, Q., Weiss, J. M. and Wiltrout, R. H. (2012). A matched couple: Combining kinase inhibitors with immunotherapy for cancer treatment. Oncoimmunology 1(1): 115-117.
   
5. Stauffer, J. K., Scarzello, A. J., Jiang, Q. and Wiltrout, R. H. (2012). Chronic inflammation, immune escape, and oncogenesis in the liver: a unique neighborhood for novel intersections. Hepatology 56(4): 1567-1574.
   
6. Jiang, Q., Weiss, J. M., Back, T., Chan, T., Ortaldo, J. R., Guichard, S. and Wiltrout, R. H. (2011). mTOR kinase inhibitor AZD8055 enhances the immunotherapeutic activity of an agonist CD40 antibody in cancer treatment. Cancer Res 71(12): 4074-4084.
   
7. Subleski, J. J., Jiang, Q., Weiss, J. M. and Wiltrout, R. H. (2011). The split personality of NKT cells in malignancy, autoimmune and allergic disorders. Immunotherapy 3(10): 1167-1184.
   
8. Jiang, Q., Wei, H. and Tian, Z. (2008). Poly I:C enhances cycloheximide-induced apoptosis of tumor cells through TLR3 pathway. BMC Cancer 8: 12.
   
9. Jiang, Q., Wei, H. and Tian, Z. (2008). IFN-producing killer dendritic cells contribute to the inhibitory effect of poly I:C on the progression of murine melanoma. J Immunother 31(6): 555-562.